ARCHIVES

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

ODAC Votes 13:0 For Approving Perjeta

September 27, 2013

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010

Study: Molecular Breast Imaging Can Be As Effective as MRI

July 27, 2012

Ethics Commission Say HHS Should Test Injury Compensation

June 18, 1982

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006

In Brief: New Contract To Speed Drug Development Planned; Groups To Get $5.6 Million Extra

February 27, 1976